Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venetoclax + Chemotherapy in Acute Lymphoblastic Leukemia
NCT03319901Phase 2Active, not recruiting
- Sponsor
- Dana-Farber Cancer Institute
- Start
- Oct 2017
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of venetoclax in acute lymphoblastic leukemia (ALL), sponsored by Dana-Farber Cancer Institute. Started Oct 2017; status: active, not recruiting.
02
Drugs
venetoclax
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT03319901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03319901.